Global Contract Pharmaceutical Manufacturing Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Contract Pharmaceutical Manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing. Scope of the Report: Contract Pharmaceutical Manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and so on, which required for pharmaceutical manufacturing. The main type of contract pharmaceutical manufacturing is API and FDF. The contract pharmaceutical manufacturing industry is not very concentrated the revenue of top eighteenth manufacturers account about 22% of global revenue. In the world wide, the major manufactures mainly distribute in North America and Europe. The transnational companies, like Catalent and DPx, are the leading manufactures in the World. North America and Europe is the industry's leading region. In 2015, the revenue of contract pharmaceutical manufacturing is about 19 billion USD in North America; its proportion of total global revenue exceeds 32%. In 2015, the revenue is about 14 billion USD in Europe. Japan and India have witnessed a major chunk developing of the contract pharmaceutical manufacturing in the Asia region. Especially India, its revenue is 8 billion USD in 2015. The worldwide market for Contract Pharmaceutical Manufacturing is expected to grow at a CAGR of roughly 5.8% over the next five years, will reach 96400 million US$ in 2024, from 68700 million US$ in 2019, according to a new GIR (Global Info Research) stu ...
Table of Contents 1 Market Overview 1.1 Contract Pharmaceutical Manufacturing Introduction 1.2 Market Analysis by Type 1.2.1 API 1.2.2 FDF 1.3 Market Analysis by Applications 1.3.1 Specialty/Midsize 1.3.2 Generics 1.3.3 Big Pharma 1.3.4 Other 1.4 Market Analysis by Regions 1.4.1 North America (United States, Canada and Mexico) 1.4.1.1 United States Market States and Outlook (2014-2024) 1.4.1.2 Canada Market States and Outlook (2014-2024) 1.4.1.3 Mexico Market States and Outlook (2014-2024) 1.4.2 Europe (Germany, France, UK, Russia and Italy) 1.4.2.1 Germany Market States and Outlook (2014-2024) 1.4.2.2 France Market States and Outlook (2014-2024) 1.4.2.3 UK Market States and Outlook (2014-2024) 1.4.2.4 Russia Market States and Outlook (2014-2024) 1.4.2.5 Italy Market States and Outlook (2014-2024) 1.4.3 ...
7701

7109

OUR CLIENT